Announcement PDF ASX Release 30 September 2025 Announcement Date of AGM and closing date for director nominations Melbourne, Australia; Acrux Limited (ASX:ACR) advises that, in accordance with ASX Listing Rule 3.13.1, Acrux's next Annual General Meeting (AGM) will be held on Tuesday, 25 November 2025 at 10:00 am (AEDT) in the offices of Pitcher Partners, Level 13, 664 Collins St, Docklands, Melbourne. An item of business will be the election of directors. In accordance with ASX Listing Rule 14.3, the Company will accept valid nominations from persons wishing to be considered for election as a director up to 35 business days before the AGM date. Consequently, nominations must be received by the Company no later than 5.00 pm AEDT on Friday, 10 October 2025. Nominations may be delivered to the Company’s registered office or emailed to the Company Secretary, Joanna.johnson@acrux.com.au. Further information in relation to the AGM will be provided to Shareholders in due course and the Notice of Meeting will also be available on the ASX Market Announcements Platform and the Company’s website. Authorised for release by the Board of Acrux Limited. For more information, please contact: John Warmbrunn Acrux Limited CEO & Managing Director P: + 61 3 8379 0100 E: john.warmbrunn@acrux.com.au About Acrux Acrux is a specialty pharma company with a successful track record of developing and commercialising a pipeline of topically applied pharmaceutical products. Drawing on 25 years of experience, Acrux has successfully marketed through licensees a number of products worldwide with emphasis on the United States. For further information on Acrux, visit www.acrux.com.au